The silibinin-loaded Zein-β cyclodextrin nano-carriers (SZBC-NCs) as a novel selective cancer cell drug delivery system in HT-29 cell line
Open Access
- 26 June 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-9
Abstract
Entrapping phytochemical bioactive compounds into nano-structured biocompatible polymers has been successfully utilized for improving cancer treatment efficiency. Silibinin is a potent compound that shows promising anticancer properties. In the present study, the Zein-β-cyclodextrin complex was used to encapsulate silibinin and evaluate the induced cell death type and cytotoxic impacts on human cancer cells. The silibinin-loaded Zein-β cyclodextrin nano-carriers (SZBC-NCs) were synthesized utilizing a gradual ultrasound-mediated homogenization technique and characterized by Zeta potential, DLS, FESEM, and FTIR analysis. The SZBC-NCs’ antioxidant activity was studied by conducting ABTS and DPPH radical scavenging assays. Finally, the SZBC-NCs selective toxicity and cellular death induction mechanism were studied on the HT-29 and AGS cancer cells by measuring the cell survival and apoptotic gene (Caspase 3, 9), respectively, which were verified by conducting the DAPI staining analysis. The negatively charged (− 27.47 mV) nanoparticles (286.55 nm) showed significant ABTS and DPPH radical scavenging activity. Moreover, the remarkable decrease in the IC50 concentrations of the SZBC-NCs among the HT-29 and AGS cancer cell lines exhibited their selective cytotoxic potential. Also, the overexpressed apoptotic (Caspases 3 and 9) and down-regulated necrotic (NFKB) gene expressions following the SZBC-NCs treatment doses indicated the apoptotic activity of SZBC-NCs, which were verified by the increased apoptotic morphology of the DAPI-stained HT-29 cancer cells. The antioxidant and colon cancer cell-related apoptotic activity of the SZBC-NCs make it an appropriate anti-colon cancer nano delivery system. Therefore, they can potentially be used as a safe efficient colon cancer treatment strategy. However, further in vivo experiments including animal cancer models have to be studied.Keywords
This publication has 36 references indexed in Scilit:
- Fabrication of Zein‐Based Fibrous Scaffolds for Biomedical Applications—A ReviewMacromolecular Materials and Engineering, 2023
- Co‐administration of curcumin with other phytochemicals improves anticancer activity by regulating multiple molecular targetsPhytotherapy Research, 2023
- Zein nanoparticles for drug delivery: Preparation methods and biological applicationsInternational Journal of Pharmaceutics, 2023
- The current and future incidence and mortality of gastric cancer in 185 countries, 2020–40: A population-based modelling studyeClinicalMedicine, 2022
- Cells electric charge analyses define specific properties for cancer cells activityBioelectrochemistry, 2022
- Drug release study of the chitosan-based nanoparticlesHeliyon, 2021
- Dynamic light scattering: a practical guide and applications in biomedical sciencesBiophysical Reviews, 2016
- Zein/cellulose acetate hybrid nanofibers: Electrospinning and characterizationMacromolecular Research, 2014
- Chitosan-based drug delivery systemsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2012
- Comparative Studies of the Enhancing Effects of Cyclodextrins on the Solubility and Oral Bioavailability of Tacrolimus in RatsJournal of Pharmaceutical Sciences, 2001